Quarter Period Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7551556

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
Quarter period statement of income
Statement of income
Net sales
14,420,000,000 JPY
1,560,000,000 JPY
16,036,000,000 JPY
16,023,000,000 JPY
55,000,000 JPY
-13,000,000 JPY
44,000,000 JPY
15,269,000,000 JPY
13,646,000,000 JPY
-15,000,000 JPY
1,593,000,000 JPY
15,284,000,000 JPY
Cost of sales
8,559,000,000 JPY
8,017,000,000 JPY
Gross profit (loss)
7,463,000,000 JPY
7,252,000,000 JPY
Selling, general and administrative expenses
5,759,000,000 JPY
5,587,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
2,021,000,000 JPY
-1,000,000 JPY
1,993,000,000 JPY
1,704,000,000 JPY
-27,000,000 JPY
-288,000,000 JPY
-18,000,000 JPY
1,664,000,000 JPY
1,728,000,000 JPY
-169,000,000 JPY
124,000,000 JPY
1,833,000,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Dividend income
178,000,000 JPY
177,000,000 JPY
Non-operating income
197,000,000 JPY
212,000,000 JPY
Non-operating expenses
Interest expenses
11,000,000 JPY
13,000,000 JPY
Non-operating expenses
93,000,000 JPY
71,000,000 JPY
Ordinary profit (loss)
1,809,000,000 JPY
1,805,000,000 JPY
Extraordinary income
Extraordinary income
64,000,000 JPY
JPY
Profit (loss) before income taxes
1,873,000,000 JPY
1,805,000,000 JPY
Income taxes - current
346,000,000 JPY
199,000,000 JPY
Income taxes - deferred
98,000,000 JPY
283,000,000 JPY
Income taxes
444,000,000 JPY
482,000,000 JPY
Profit (loss)
1,428,000,000 JPY
1,323,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.